CAS: 92309-29-0; (Z)-7-(((R)-2-Amino-2-Carboxyethyl)Thio)-2-((S)-2,2-Dimethylcyclopropane-1-Carboxamido)Hept-2-Enoic Acid--(5R,6S)-3-((2-((Aminomethylene)Amino)Ethyl)Thio)-6-((R)-1-Hydroxyethyl)-7-Oxo-1-Azabicyclo[3.2.0]Hept-2-Ene-2-Carboxylic Acid (1/1)

该化合物是一种无菌的,淋巴化的结合体,它包括聚苯乙烯,一种广泛频谱的碳酸丙胺抗生素,和硅酸钠,一种肾上脱氢苯丙胺抑制剂.这种配方通过防止肾脏退化,从而提高治疗效率,增强了聚苯乙烯的稳定.产品显示出对包括多种抗药菌株在内的各种成腺阳性和抗药性细菌的强大活动.其水体形式确保了持续的溶性性和重组性,使之适合静脉注射.这种结合在治疗诸如腹部内,呼吸道和尿道感染等严重感染以及化粪症方面特别宝贵.其可靠的药用植物基因特征和最小的肾中毒风险强调了它的临床用途.

结构式图片

MSDS等安全信息

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-10370455-B2
    优先权日:2014-12-05
    标题 :Identification of VSIG8 as the putative VISTA receptor (V-R) and use thereof to produce VISTA/VSIG8 agonists and antagonists
    发明人:MOLLOY MICHAEL; GUO YALIN; ROTHSTEIN JAY; ROSENZWEIG MICHAEL
    权利人:IMMUNEXT INC
    摘要:The receptor for VISTA is identified (VSIG8) as well as the use of this receptor in the identification or synthesis of agonist or antagonist compounds, preferably antibodies, polypeptides and fusion proteins which agonize or antagonize the effects of VSIG8 and/or VISTA and/or the VSIG8/VISTA binding interaction. These antagonists may be used to suppress VISTA's suppressive effects on T cell immunity, and more particularly used in the treatment of cancer, or infectious disease. These agonist compounds may be used to potentiate or enhance VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity, such as in the treatment of autoimmunity, allergy or inflammatory conditions. Screening assays for identifying these agonists and antagonist compounds are also provided.

    专利号:US-2023364251-A1
    优先权日:2020-08-06
    标 题:Methods for the synthesis of protein-drug conjugates
    发明人:BORCHARDT ALLEN; HUGHES ROBERT MICHAEL
    权利人:CIDARA THERAPEUTICS INC
    摘要:The present invention relates to intermediates and methods for synthesizing protein-drug conjugates that can be used for the treatment of diseases and related conditions.

    专利号:TW-202220698-A
    优先权日:2020-08-06
    标题:Methods for the synthesis of protein-drug conjugates

    专利号:EP-4192512-A1
    优先权日:2020-08-06
    标题 :Methods for the synthesis of protein-drug conjugates

    专利号:US-2007148246-A1
    优先权日:2005-08-11
    标题:Nucleic Acid-Based Matrixes
    发明人:LUO DAN; LI YOUGEN
    权利人:LUO DAN; LI YOUGEN
    摘要:Various nucleic acid-based matrixes are provided, comprising nucleic acid monomers as building blocks, as well as nucleic acids encoding proteins, so as to produce novel biomaterials. Methods of utilizing such biomaterials include delivery of biologically active agents, cell and tissue culture, and cell-free protein synthesis.

    专利号:US-2019352262-A1
    优先权日:2017-02-01
    标题 :New Pleuromutilin Antibiotic Compounds, Compositions and Methods of Use and Synthesis
    发明人:HERZON SETH; MURPHY STEPHEN K; ZENG MINGSHUO
    权利人:UNIV YALE
    摘要:The present invention is directed to novel pleuroniutilin antibiotic compounds, intermediates which are useful for making these novel amibioiic compounds and related methods and pharmaceutical compositions for treating pathogens, especially bacterial infections, including gram negative bacteria and synthesizing these compounds.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1093/ajhp/53.17.2097
    摘要:Guglielmo BJ, Jacobs RA. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin. Am J Health Syst Pharm. 1996 Sep 01;53(17):2097–8. doi: 10.1093/ajhp/53.17.2097.
    摘要:Baron TH, Morgan DE, Vickers SM, Lazenby AJ. Organized pancreatic necrosis: endoscopic, radiologic, and pathologic features of a distinct clinical entity. Pancreas. 1999 Jul;19(1):105–8.
    摘要:Kobayashi K, Yano S, Kato K, Morita M, Tatsukawa T, Ikeda T, Tokushima T. [A case of M. fortuitum lung disease with small-cell lung cancer]. Nihon Kokyuki Gakkai Zasshi. 2004 May;42(5):424–8.
    摘要:Furuya T, Soeno T, Komatsu M. [Strategy for bacterial translocation in acute pancreatitis]. Nihon Shokakibyo Gakkai Zasshi. 2004 May;101(5):502–9.
    参考文献:10.1177/1098612x12471526
    摘要:Albarellos GA, Denamiel GA, Montoya L, Quaine PC, Lupi MP, Landoni MF. Pharmacokinetics of imipenem after intravenous, intramuscular and subcutaneous administration to cats. Journal of Feline Medicine and Surgery. 2012 Dec 19;15(6):483–7. doi: 10.1177/1098612x12471526.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知